Rituxan and haemoglobin decreased Patient Reports February 11, 2012

Rituxan Side Effects Report #4674124-8
Rituxan side effect was reported by a Health Professional from on May 09, 2005. Male patient, 64 years of age, weighting 140.0 lb, was diagnosed with waldenstrom's macroglobulinaemia and was treated with Rituxan. After drug was administered, patient experienced the following side effects: activated partial thromboplastin time prolonged, aortic atherosclerosis, atelectasis, blood pressure decreased, blood urea increased, bowel sounds abnormal, coagulopathy, haemoglobin decreased, heart rate increased. Rituxan dosage: 680 MG, 1/WEEK, INTRAVENOUS. During the same period patient was treated with GLUCOPHAGE, SERZONE, NEXIUM, BEXTRA, UROXATRAL, FERREX, EFFEXOR, PROCRIT. Patient was hospitalized. Patient recovered.

Rituxan Side Effects Report #5273406-9
Rituxan side effect was reported by a Physician from UNITED KINGDOM on Mar 14, 2007. Female patient, 56 years of age, was diagnosed with rheumatoid arthritis  and was treated with Rituxan. After drug was administered, patient experienced the following side effects: atelectasis, c-reactive protein increased, chest pain , haemoglobin decreased, hypoxia, lymphocyte count decreased, neutrophil count decreased, pericardial rub, pleuritic pain. Rituxan dosage: unknown. During the same period patient was treated with METHOTREXATE, PREDNISOLONE, FOLIC ACID, ALENDRONATE, CALCICHEW DE, AMITRIPRYLINE, KETOPROFEN. Patient was hospitalized. Patient recovered.

Rituxan Side Effects Report #5519715-7
Rituxan side effect was reported by a Consumer or non-health professional from UNITED STATES on Nov 09, 2007. Female patient was diagnosed with rheumatoid arthritis  and was treated with Rituxan. After drug was administered, patient experienced the following side effects: haemoglobin decreased. Rituxan dosage: 1000 MG, DAYS 1+15. During the same period patient was treated with ALEVE, LODINE, FIBERCON. Patient recovered.

Rituxan Side Effects Report #4811728-3
Rituxan side effect was reported by a Physician from JAPAN on Oct 12, 2005. Female patient, child 10 years of age, was diagnosed with prophylaxis against transplant rejection, immunosuppression and was treated with Rituxan. After drug was administered, patient experienced the following side effects: blood albumin increased, blood immunoglobulin m decreased, cytomegalovirus infection , haemoglobin decreased, liver transplant rejection, platelet count increased, pneumocystis jiroveci pneumonia. Rituxan dosage: 380 MG, SINGLE, INTRAVENOUS. During the same period patient was treated with MYCOPHENOLATE MOFETIL, TACROLIMUS, METHYLPREDNISOLONE, STEROID, BASILIXIMAB, FOSCARNET, FRESH FROZEN PLASMA. Patient died on 06/19/2004.


Rituxan Side Effects Report #4764408-7
Rituxan side effect was reported by a Physician from JAPAN on Aug 24, 2005. Male patient, 88 years of age, weighting 123.5 lb, was diagnosed with non-hodgkin's lymphoma and was treated with Rituxan. After drug was administered, patient experienced the following side effects: anaemia, blood alkaline phosphatase increased, blood creatinine increased, blood potassium increased, blood urea increased, haemoglobin decreased, platelet count decreased, pneumonia , protein urine present. Rituxan dosage: 600 MG, INTRAVENOUS. During the same period patient was treated with THERARUBICIN, CYCLOPHOSPHAMIDE, ONCOVIN, PREDONINE, HYDROCORTISONE, FAMOTIDINE. Patient died on 04/08/2005.

Rituxan Side Effects Report #4686708-1
Rituxan side effect was reported by a Physician from on May 27, 2005. Male patient, 83 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with Rituxan. After drug was administered, patient experienced the following side effects: haemoglobin decreased, platelet count increased, pneumonia , white blood cell count decreased. Rituxan dosage: 500 MG, IV DRIP. During the same period patient was treated with IRINOTECAN, DEXAMETHASONE. Patient died on 11/03/2004.

Rituxan Side Effects Report #4803862-9
Rituxan side effect was reported by a Physician from JAPAN on Oct 03, 2005. Male patient, 79 years of age, weighting 101.4 lb, was diagnosed with non-hodgkin's lymphoma and was treated with Rituxan. After drug was administered, patient experienced the following side effects: convulsion, febrile neutropenia, haemoglobin decreased, platelet count decreased, white blood cell count decreased. Rituxan dosage: 532 MG, INTRAVENOUS. During the same period patient was treated with ETOPOSIDE, POLARAMINE, LOXONIN. Patient died on 11/07/2004.

Rituxan Side Effects Report #4875004-5
Rituxan side effect was reported by a Physician from JAPAN on Dec 20, 2005. Female patient, 76 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with Rituxan. After drug was administered, patient experienced the following side effects: blood pressure decreased, blood sodium decreased, chills, difficulty in walking, dizziness , haemoglobin decreased, neutrophil count decreased, platelet count decreased, white blood cell count decreased. Rituxan dosage: 550 MG, UNK; INTRAVENOUS. During the same period patient was treated with DOXORUBICIN HYDROCHLORIDE, CYCLOPHOSPHAMIDE, ONCOVIN, PREDONINE, IBUPROFEN, DEXCHLORPHENIRAMINE MALEATE, NIFEDIPINE. Patient recovered.

Rituxan Side Effects Report #4700710-2
Rituxan side effect was reported by a Physician from on June 10, 2005. Male patient, 75 years of age, weighting 110.2 lb, was diagnosed with non-hodgkin's lymphoma and was treated with Rituxan. After drug was administered, patient experienced the following side effects: abdominal pain upper, chest discomfort, diarrhoea, gastric ulcer haemorrhage, haemoglobin decreased, pyrexia, white blood cell count decreased. Rituxan dosage: 600 MG, INTRAVENOUS. During the same period patient was treated with POLARAMINE, ALLOPURINOL, PROMAC, MUCOSTA, SEROTONE, EPINEPHRINE, THROMBIN LOCAL SOLUTION. Patient was hospitalized. Patient recovered.


Rituxan Side Effects Report #4713391-9
Rituxan side effect was reported by a Physician from JAPAN on June 30, 2005. Male patient, 75 years of age, weighting 110.2 lb, was diagnosed with non-hodgkin's lymphoma and was treated with Rituxan. After drug was administered, patient experienced the following side effects: abdominal pain upper, chest discomfort, diarrhoea, gastric ulcer haemorrhage, haemoglobin decreased, mantle cell lymphoma, pyrexia, tumour lysis syndrome, white blood cell count decreased. Rituxan dosage: 600 MG, UNK; INTRAVENOUS. During the same period patient was treated with POLARAMINE, ALLOPURINOL, PROMAC, MUCOSTA, SEROTONE, EPINEPHRINE, THROMBIN. Patient was hospitalized. Patient recovered.

Rituxan Side Effects Report #5114962-0
Rituxan side effect was reported by a Health Professional from JAPAN on Sept 08, 2006. Male patient, 74 years of age, weighting 224.9 lb, was diagnosed with non-hodgkin's lymphoma and was treated with Rituxan. After drug was administered, patient experienced the following side effects: fibrin increased, haemodialysis, haemoglobin decreased, hepatic encephalopathy, hepatic failure, hepatitis b , monocyte percentage increased, red blood cell count decreased, renal failure. Rituxan dosage: 800 MG, INTRAVENOUS. During the same period patient was treated with ENDOXAN, ETOPOSIDE, DECADRON, ALKERAN. Patient died on 06/21/2006.

Rituxan Side Effects Report #5227071-7
Rituxan side effect was reported by a Physician from JAPAN on Jan 27, 2007. Female patient, 72 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with Rituxan. After drug was administered, patient experienced the following side effects: haemoglobin decreased, osteonecrosis , pain , platelet count abnormal, red blood cell count abnormal, white blood cell count abnormal. Rituxan dosage: 500 MG, INTRAVENOUS. During the same period patient was treated with CYCLOPHOSPHAMIDE, DOXORUBICIN, ONCOVIN, PREDNISOLONE, VEPESID. Patient recovered.

Rituxan Side Effects Report #4885945-0
Rituxan side effect was reported by a Consumer or non-health professional from JAPAN on Jan 03, 2006. Male patient, 72 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with Rituxan. After drug was administered, patient experienced the following side effects: haemoglobin decreased, non-hodgkin's lymphoma recurrent, oesophagobronchial fistula, pneumonia aspiration, protein total decreased, sputum culture positive, staphylococcal infection , white blood cell count decreased. Rituxan dosage: 600 MG, X4. During the same period patient was treated with CYCLOPHOSPHAMIDE, VINCRISTINE, DOXORUBICIN, PREDNISONE. Patient was hospitalized. Patient recovered.

Rituxan Side Effects Report #4855618-9
Rituxan side effect was reported by a Physician from JAPAN on Dec 01, 2005. Male patient, 71 years of age, weighting 116.8 lb, was diagnosed with non-hodgkin's lymphoma and was treated with Rituxan. After drug was administered, patient experienced the following side effects: cytomegalovirus infection , diverticular hernia, gastrointestinal infection, haemoglobin decreased, post procedural complication, shock, small intestinal haemorrhage, small intestine ulcer, thrombocytopenia. Rituxan dosage: 375 MG/M2,. During the same period patient was treated with NOVANTRONE, FLUDARABINE PHOSPHATE, DECADRON, BLOOD TRANSFUSION, PLATELETS, GANCICLOVIR, FOSCAVIR. Patient recovered.


Rituxan Side Effects Report #4958823-6
Rituxan side effect was reported by a Physician from JAPAN on Mar 16, 2006. Male patient, 71 years of age, weighting 116.8 lb, was diagnosed with non-hodgkin's lymphoma and was treated with Rituxan. After drug was administered, patient experienced the following side effects: abdominal pain lower, cytomegalovirus gastroenteritis, cytomegalovirus infection , diverticular hernia, haematochezia, haemoglobin decreased, inflammation, melaena. Rituxan dosage: 375 MG/M2, INTRAVENOUS. During the same period patient was treated with NOVANTRONE, FLUDARABINE, DECADRON, BLOOD TRANSFUSION, PLATELETS, NEUTROGEN. Patient recovered.

Rituxan Side Effects Report #4783674-5
Rituxan side effect was reported by a Consumer or non-health professional from CHINA on Sept 21, 2005. Male patient, 70 years of age, weighting 88.18 lb, was diagnosed with non-hodgkin's lymphoma and was treated with Rituxan. After drug was administered, patient experienced the following side effects: haemoglobin decreased, neutrophil count decreased, platelet count decreased, pyrexia, white blood cell count decreased. Rituxan dosage: 477.261MG, Q3W, INTRAVENOUS. During the same period patient was treated with CYCLOPHOSPHAMIDE, DOXORUBICIN, VINCRISTINE, PREDNISONE, POLARAMINE, HYDROCORTONE, LEVOFLOXACIN, FLUCONAZOLE. Patient recovered.

Rituxan Side Effects Report #4810041-8
Rituxan side effect was reported by a Physician from JAPAN on Oct 11, 2005. Male patient, 70 years of age, weighting 110.2 lb, was diagnosed with non-hodgkin's lymphoma and was treated with Rituxan. After drug was administered, patient experienced the following side effects: blood creatinine increased, blood lactate dehydrogenase increased, blood potassium increased, blood urea increased, haemoglobin decreased, lymphocyte percentage increased, neutrophil percentage decreased, platelet count decreased, red blood cell count decreased. Rituxan dosage: 530 MG, QD. During the same period patient was treated with CYCLOPHOSPHAMIDE, DOXORUBICIN HYDROCHLORIDE, VINCRISTINE, PREDNISONE, GRANISETRON, ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, PANIPENEM. Patient recovered.

Rituxan Side Effects Report #4810392-7
Rituxan side effect was reported by a Physician from JAPAN on Oct 11, 2005. Male patient, 70 years of age, weighting 110.2 lb, was diagnosed with non-hodgkin's lymphoma and was treated with Rituxan. After drug was administered, patient experienced the following side effects: blood creatine increased, blood lactate dehydrogenase increased, blood urea increased, haemoglobin decreased, lymphocyte percentage decreased, lymphocyte percentage increased, neutrophil percentage decreased, platelet count decreased, red blood cell count decreased. Rituxan dosage: 530 MG, QD,. During the same period patient was treated with CYCLOPHOSPHAMIDE, DOXORUBICIN HYDROCHLORIDE, VINCRISTINE, PREDNISONE, GRANISETRON, ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, PANIPENEM. Patient recovered.

Rituxan Side Effects Report #4811725-8
Rituxan side effect was reported by a Physician from JAPAN on Oct 11, 2005. Male patient, 70 years of age, weighting 110.2 lb, was diagnosed with non-hodgkin's lymphoma and was treated with Rituxan. After drug was administered, patient experienced the following side effects: abdominal pain , blood lactate dehydrogenase increased, cough, haemoglobin decreased, hypokalaemia, neutrophil percentage decreased, platelet count decreased, pleurisy, pyrexia. Rituxan dosage: 530 MG, INTRAVENOUS. During the same period patient was treated with CYCLOPHOSPHAMIDE, DOXORUBICIN HYDROCHLORIDE, VINCRISTINE SULPHATE, PREDNISOLONE ACETATE, DEXAMETHASONE PHOSPHATE, GRANISETRON, AMIKACIN SULPHATE, AMPHOTERICIN B. Patient recovered.


Rituxan Side Effects Report #5264271-4
Rituxan side effect was reported by a Physician from JAPAN on Feb 23, 2007. Male patient, 68 years of age, weighting 152.1 lb, was diagnosed with non-hodgkin's lymphoma and was treated with Rituxan. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, bilirubin conjugated increased, blood bilirubin increased, gastric ulcer, gastrointestinal haemorrhage, haemoglobin decreased, helicobacter infection. Rituxan dosage: 375 MG, QD, INTRAVENOUS. During the same period patient was treated with FERROMIA, LASIX, ALDACTONE, URSO, OCTOTIAMINE, ASPARA, CHINESE MEDICINE, MOSAPRIDE CITRATE. Patient recovered.

Rituxan Side Effects Report #4942941-2
Rituxan side effect was reported by a Physician from JAPAN on Feb 24, 2006. Female patient, 67 years of age, weighting 116.8 lb, was diagnosed with non-hodgkin's lymphoma and was treated with Rituxan. After drug was administered, patient experienced the following side effects: aspartate aminotransferase increased, haemoglobin decreased, neutrophil count decreased, white blood cell count decreased. Rituxan dosage: 550 MG, INTRAVENOUS. During the same period patient was treated with DOXORUBICIN HYDROCHLORIDE, CYCLOPHOSPHAMIDE, ONCOVIN, BRUFEN, POLARAMINE, NORVASC. Patient recovered.

Rituxan Side Effects Report #4718908-6
Rituxan side effect was reported by a Physician from JAPAN on July 08, 2005. Female patient, 66 years of age, weighting 141.1 lb, was diagnosed with non-hodgkin's lymphoma, diffuse large b-cell lymphoma and was treated with Rituxan. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, gamma-glutamyltransferase increased, haemoglobin decreased, nausea , neutrophil count decreased, platelet count decreased. Rituxan dosage: 590 MG, INTRAVENOUS. During the same period patient was treated with IFOSFAMIDE, PARAPLATIN, VEPESID, MESNA, POLARAMINE, IBUPROFEN. Patient recovered.

Rituxan Side Effects Report #5067764-8
Rituxan side effect was reported by a Physician from UNITED STATES on July 20, 2006. Male patient, 65 years of age, weighting 175.9 lb, was diagnosed with non-hodgkin's lymphoma and was treated with Rituxan. After drug was administered, patient experienced the following side effects: gastrointestinal haemorrhage, haematemesis, haematocrit decreased, haemoglobin decreased, hypotension, melaena, platelet count increased, prothrombin time prolonged. Rituxan dosage: 375 MG/M2, INTRAVENOUS. During the same period patient was treated with CYCLOPHOSPHAMIDE, ADRIAMYCIN PFS, VINCRISTINE, PREDNISONE, ACETAMINOPHEN, BENADRYL, ZOFRAN, ATENOLOL. Patient was hospitalized. Patient recovered.

Rituxan Side Effects Report #4805785-8
Rituxan side effect was reported by a Physician from UNITED STATES on Oct 05, 2005. Female patient, 65 years of age, weighting 194.9 lb, was diagnosed with non-hodgkin's lymphoma and was treated with Rituxan. After drug was administered, patient experienced the following side effects: bronchiectasis, bronchitis acute, effusion, haemoglobin decreased, interstitial lung disease, neutrophil percentage decreased, white blood cell count decreased. Rituxan dosage: unknown. During the same period patient was treated with CYTOXAN, FLUDARA, TAMOXIFEN CITRATE, ELAVIL, BACTRIM DS, VALTREX, PREDNISONE. Patient recovered.


Rituxan Side Effects Report #4868781-0
Rituxan side effect was reported by a Consumer or non-health professional from JAPAN on Dec 14, 2005. Male patient, 65 years of age, weighting 136.7 lb, was diagnosed with non-hodgkin's lymphoma and was treated with Rituxan. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, gangrene, haemoglobin decreased, hepatic function abnormal. Rituxan dosage: 650 MG, INTRAVENOUS. During the same period patient was treated with THERARUBICIN, CYCLOPHOSPHAMIDE, ONCOVIN, METHOTREXATE, FAMOTIDINE, TEGRETOL, VERAPAMIL, ISONIAZID. Patient was hospitalized. Patient recovered.

Rituxan Side Effects Report #4902361-3
Rituxan side effect was reported by a Consumer or non-health professional from JAPAN on Jan 20, 2006. Male patient, 65 years of age, weighting 136.7 lb, was diagnosed with non-hodgkin's lymphoma and was treated with Rituxan. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, gangrene, haemoglobin decreased, platelet count decreased, white blood cell count decreased. Rituxan dosage: 650 MG, INTRAVENOUS. During the same period patient was treated with THERARUBICIN, ENDOXAN, ONCOVIN, METHOTREXATE, FAMOTIDINE, TEGRETOL, VERAPAMIL, ISONIAZID. Patient was hospitalized. Patient recovered.

Rituxan Side Effects Report #4911383-8
Rituxan side effect was reported by a Physician from JAPAN on Feb 06, 2006. Male patient, 65 years of age, weighting 136.7 lb, was diagnosed with non-hodgkin's lymphoma and was treated with Rituxan. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, gangrene, haemoglobin decreased, hepatic function abnormal, platelet count decreased, white blood cell count decreased. Rituxan dosage: 650 MG, INTRAVENOUS. During the same period patient was treated with THERARUBICIN, ENDOXAN, ONCOVIN, METHOTREXATE, FAMOTIDINE, TEGRETOL, VERAPAMIL, ISONIAZID. Patient was hospitalized. Patient recovered.

Rituxan Side Effects Report #4930277-5
Rituxan side effect was reported by a Physician from JAPAN on Feb 15, 2006. Male patient, 65 years of age, weighting 136.7 lb, was diagnosed with non-hodgkin's lymphoma and was treated with Rituxan. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, diabetic gangrene, haemoglobin decreased, hepatic function abnormal, platelet count decreased, white blood cell count decreased. Rituxan dosage: 650 MG, INTRAVENOUS. During the same period patient was treated with THERARUBICIN, ENDOXAN, ONCOVIN, METHOTREXATE, FAMOTIDINE, TEGRETOL, VERAPAMIL, ISONIAZID. Patient was hospitalized. Patient recovered.

Rituxan Side Effects Report #4933998-3
Rituxan side effect was reported by a Physician from JAPAN on Mar 01, 2006. Male patient, 65 years of age, weighting 136.7 lb, was diagnosed with non-hodgkin's lymphoma and was treated with Rituxan. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, gangrene, haemoglobin decreased, hepatic function abnormal, platelet count decreased, white blood cell count decreased. Rituxan dosage: 650 MG, INTRAVENOUS. During the same period patient was treated with THERARUBICIN, ENDOXAN, ONCOVIN, METHOTREXATE, FAMOTIDINE, TEGRETOL, VERAPAMIL, ISONIAZID. Patient was hospitalized. Patient recovered.


Rituxan Side Effects Report #4921434-2
Rituxan side effect was reported by a Health Professional from JAPAN on Feb 10, 2006. Male patient, 64 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with Rituxan. After drug was administered, patient experienced the following side effects: gamma-glutamyltransferase increased, haemoglobin decreased, neutrophil count decreased, white blood cell count decreased. Rituxan dosage: 640 MG, INTRAVENOUS. During the same period patient was treated with DOXORUBICIN, CYCLOPHOSPHAMIDE, VINCRISTINE, PREDNISOLONE, IBUPROFEN, CHLORPHENIRAMINE MALEATE, FAMOTIDINE, IRSOGLADINE MALEATE. Patient recovered.

Rituxan Side Effects Report #4939324-8
Rituxan side effect was reported by a Physician from JAPAN on Feb 22, 2006. Male patient, 64 years of age, weighting 119.0 lb, was diagnosed with non-hodgkin's lymphoma and was treated with Rituxan. After drug was administered, patient experienced the following side effects: chills, haemoglobin decreased, hypoaesthesia oral, interstitial lung disease, neutrophil percentage decreased, white blood cell count decreased. Rituxan dosage: 600 MG, INTRAVENOUS. During the same period patient was treated with CYCLOPHOSPHAMIDE, DOXORUBICIN, VINCRISTINE, PREDNISONE, HYDROCORTISONE, IBUPROFEN, HYDROXYZINE, ONDANSETRON. Patient recovered.

Rituxan Side Effects Report #4822589-0
Rituxan side effect was reported by a Physician from JAPAN on Oct 25, 2005. Female patient, 63 years of age, weighting 125.7 lb, was diagnosed with non-hodgkin's lymphoma and was treated with Rituxan. After drug was administered, patient experienced the following side effects: haemoglobin decreased, neutrophil count decreased, pyrexia, white blood cell count decreased. Rituxan dosage: 580 MG, INTRAVENOUS. During the same period patient was treated with CYCLOPHOSPHAMIDE, DOXORUBICIN, VINCRISTINE, PREDNISONE, LOXONIN. Patient recovered.

Rituxan Side Effects Report #4694959-5
Rituxan side effect was reported by a Physician from on June 08, 2005. Female patient, 60 years of age, weighting 110.2 lb, was diagnosed with non-hodgkin's lymphoma and was treated with Rituxan. After drug was administered, patient experienced the following side effects: haemoglobin decreased, neutrophil count decreased, platelet count decreased, red blood cell count decreased, white blood cell count decreased. Rituxan dosage: 520 MG, 1/MONTH, INTRAVENOUS. During the same period patient was treated with CYCLOPHOSPHAMIDE, VINCRISTINE, DOXORUBICIN HYDROCHLORIDE, PREDNISONE, IBUPROFEN, CHLORPHENIRAMINE MALEATE. Patient recovered.

Rituxan Side Effects Report #4688451-1
Rituxan side effect was reported by a Physician from on May 25, 2005. Female patient, 58 years of age, weighting 98.11 lb, was diagnosed with non-hodgkin's lymphoma and was treated with Rituxan. After drug was administered, patient experienced the following side effects: anaphylactoid reaction, haemoglobin decreased, pyrexia. Rituxan dosage: 500 MG, INTRAVENOUS. During the same period patient was treated with CALONAL, CHLOR, SELBEX, FAMOTIDINE. Patient recovered.


Rituxan Side Effects Report #4868763-9
Rituxan side effect was reported by a Consumer or non-health professional from JAPAN on Dec 13, 2005. Female patient, 57 years of age, weighting 123.5 lb, was diagnosed with non-hodgkin's lymphoma and was treated with Rituxan. After drug was administered, patient experienced the following side effects: b-cell lymphoma, febrile neutropenia, gingival pain, haemoglobin decreased, neoplasm recurrence, platelet count decreased, white blood cell count decreased. Rituxan dosage: 250 MG INTRAVENOUS. During the same period patient was treated with ZEVALIN, SHL. Patient was hospitalized. Patient recovered.

Rituxan Side Effects Report #4954446-3
Rituxan side effect was reported by a Health Professional from JAPAN on Mar 13, 2006. Female patient, 57 years of age, weighting 123.5 lb, was diagnosed with non-hodgkin's lymphoma and was treated with Rituxan. After drug was administered, patient experienced the following side effects: febrile neutropenia, gingival pain, haematocrit decreased, haemoglobin decreased, platelet count decreased, white blood cell count decreased. Rituxan dosage: unknown. During the same period patient was treated with ZEVALIN, SHL. Patient was hospitalized. Patient recovered.

Rituxan Side Effects Report #4729597-9
Rituxan side effect was reported by a Physician from JAPAN on July 15, 2005. Male patient, 56 years of age, weighting 116.8 lb, was diagnosed with non-hodgkin's lymphoma and was treated with Rituxan. After drug was administered, patient experienced the following side effects: adenoviral haemorrhagic cystitis, haematocrit decreased, haemoglobin decreased, platelet count decreased, stem cell transplant, white blood cell count decreased. Rituxan dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE, ONCOVIN, ADRIAMYCIN PFS, PREDONINE, LEUSTATIN, NOVANTRON. Patient was hospitalized. Patient recovered.

Rituxan Side Effects Report #4780397-3
Rituxan side effect was reported by a Physician from JAPAN on Sept 14, 2005. Male patient, 56 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with Rituxan. After drug was administered, patient experienced the following side effects: blood pressure increased, cerebral haemorrhage, chills, haemoglobin decreased, hemiplegia, neutrophil percentage increased, paralysis , platelet count increased, pyrexia. Rituxan dosage: 24 MG, UNK; INTRAVENOUS. During the same period patient was treated with ACETAMINOPHEN, DIPHENHYDRAMINE. Patient recovered.

Rituxan Side Effects Report #4788909-0
Rituxan side effect was reported by a Physician from JAPAN on Sept 22, 2005. Male patient, 56 years of age, weighting 116.8 lb, was diagnosed with non-hodgkin's lymphoma and was treated with Rituxan. After drug was administered, patient experienced the following side effects: adenoviral haemorrhagic cystitis, haematocrit decreased, haemoglobin decreased, hypogammaglobulinaemia, platelet count decreased, stem cell transplant, white blood cell count decreased. Rituxan dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE, ONCOVIN, ADRIAMYCIN PFS, PREDONINE, LEUSTATIN, NOVANTRONE. Patient was hospitalized. Patient recovered.


Rituxan Side Effects Report #4694952-2
Rituxan side effect was reported by a Physician from on June 06, 2005. Male patient, 55 years of age, weighting 145.5 lb, was diagnosed with non-hodgkin's lymphoma and was treated with Rituxan. After drug was administered, patient experienced the following side effects: haemoglobin decreased, lymphocyte percentage decreased, neutrophil count decreased, neutrophil percentage increased, platelet count decreased. Rituxan dosage: 630 MG IV DRIP. During the same period patient was treated with CYCLOPHOSPHAMIDE, VEPESID, CYTARABINE, DECADRON, LOXONIN, DEXCHLORPHENIRAMINE MALEATE. Patient recovered.

Rituxan Side Effects Report #4694961-3
Rituxan side effect was reported by a Physician from on June 06, 2005. Male patient, 52 years of age, weighting 106.9 lb, was diagnosed with non-hodgkin's lymphoma and was treated with Rituxan. After drug was administered, patient experienced the following side effects: abdominal neoplasm, blood pressure increased, blood urea increased, chills, haemoglobin decreased, hydronephrosis, hypercalcaemia, hyperuricaemia, neoplasm progression. Rituxan dosage: 570 MG, 1/WEEK, INTRAVENOUS. During the same period patient was treated with DOXORUBICIN HYDROCHLORIDE, ATARAX, ACETAMINOPHEN, PRIMAXIN, CARBENIN, AMIKACIN SULPHATE, MORPHINE, DIFLUCAN. Patient recovered.

Rituxan Side Effects Report #4705685-8
Rituxan side effect was reported by a Physician from on June 10, 2005. Female patient, 50 years of age, weighting 85.98 lb, was diagnosed with non-hodgkin's lymphoma and was treated with Rituxan. After drug was administered, patient experienced the following side effects: bone marrow disorder, haemoglobin decreased, leukopenia, neutropenia, platelet count decreased. Rituxan dosage: 500 MG, IV DRIP. During the same period patient was treated with POLARAMINE, IBUPROFEN. Patient recovered.

Rituxan Side Effects Report #4698865-1
Rituxan side effect was reported by a Physician from on June 09, 2005. Female patient, 47 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with Rituxan. After drug was administered, patient experienced the following side effects: abdominal pain upper, alanine aminotransferase increased, aspartate aminotransferase increased, chills, disseminated intravascular coagulation, fatigue, haematocrit decreased, haemoglobin decreased, headache . Rituxan dosage: 600 MG, INTRAVENOUS. During the same period patient was treated with POLARAMINE, CALONAL, FAMOTIDINE, SELBEX, BIOFERMIN, POTASSIUM CITRATE, ALLOPURINOL, FERROMIA. Patient recovered.

Rituxan Side Effects Report #4937137-4
Rituxan side effect was reported by a Physician from JAPAN on Feb 21, 2006. Male patient, 39 years of age, weighting 156.5 lb, was diagnosed with non-hodgkin's lymphoma and was treated with Rituxan. After drug was administered, patient experienced the following side effects: c-reactive protein increased, haemoglobin decreased, neutropenia, pyrexia. Rituxan dosage: 760 MG, INTRAVENOUS. During the same period patient was treated with DECADRON, ETOPOSIDE, PARAPLATIN, IRINOTECAN, IBUPROFEN, POLARMIN, ALLOPURINOL, SEROTONE. Patient recovered.

Rituxan Side Effects Report #4851805-4
Rituxan side effect was reported by a Physician from JAPAN on Nov 28, 2005. Male patient, 37 years of age, weighting 211.6 lb, was diagnosed with non-hodgkin's lymphoma and was treated with Rituxan. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, blood potassium decreased, haemoglobin decreased, neutropenia, non-hodgkin's lymphoma recurrent, vomiting, white blood cell count decreased. Rituxan dosage: 750 MG, Q3W, INTRAVENOUS. During the same period patient was treated with LOXONIN, CARBOPLATIN, ETOPOSIDE, RESTAMIN, IRINOTECAN. Patient recovered.

Rituxan Side Effects Report #4780995-7
Rituxan side effect was reported by a Physician from JAPAN on Sept 13, 2005. Female patient, 36 years of age, weighting 125.7 lb, was diagnosed with non-hodgkin's lymphoma and was treated with Rituxan. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, dizziness , gamma-glutamyltransferase increased, haemoglobin decreased, headache , infection , nausea , neutrophil count decreased. Rituxan dosage: 585 MG, INTRAVENOUS. During the same period patient was treated with IFOSFAMIDE, PARAPLATIN, VEPESID, IBRUFEN, POLARAMINE, NEUTROGIN, MAGNESIUM OXIDE, PURSENNID. Patient recovered.

Rituxan Side Effects Report #5035069-7
Rituxan side effect was reported by a Physician from JAPAN on June 20, 2006. Male patient, 33 years of age, weighting 130.1 lb, was diagnosed with non-hodgkin's lymphoma and was treated with Rituxan. After drug was administered, patient experienced the following side effects: blood alkaline phosphatase increased, c-reactive protein increased, haemoglobin decreased, infection , neuropathy peripheral, pancytopenia. Rituxan dosage: 630 MG, UNK, INTRAVENOUS. During the same period patient was treated with ETOPOSIDE, ONCOVIN, DOXORUBICIN HYDROCHLORIDE, PREDONINE, CYCLOPHOSPHAMIDE. Patient recovered.

Rituxan Side Effects Report #5409563-0
Rituxan side effect was reported by a Physician from JAPAN on Aug 03, 2007. Male patient was diagnosed with non-hodgkin's lymphoma, gastritis, neutropenia, constipation , oedema and was treated with Rituxan. After drug was administered, patient experienced the following side effects: bradycardia, cardiac arrest , haemoglobin decreased, pneumonia klebsiella, respiratory arrest, respiratory failure, septic shock, white blood cell count decreased. Rituxan dosage: 500 MG, UNK. During the same period patient was treated with SOBUZOXANE, ETOPOSIDE, OMEPRAZOLE, SENNOSIDE, MUCOSTA, FAMOTIDINE, LASIX. Patient was hospitalized. Patient died on 07/18/2007.

Rituxan Side Effects Report #5905447-X
Rituxan side effect was reported by a Consumer or non-health professional from UNITED STATES on Oct 01, 2008. Female patient, weighting 133.0 lb, was diagnosed with non-hodgkin's lymphoma and was treated with Rituxan. After drug was administered, patient experienced the following side effects: deep vein thrombosis , haemoglobin decreased, pulmonary haemorrhage. Rituxan dosage: 375 MG/M2 Q14DAYS IV. During the same period patient was treated with CYCLOPHOSPHAMIDE, DOXORUBICIN, VINCRISTINE, PREDNISONE, PEGYLATED FILGRASTIM. Patient was hospitalized. Patient recovered.


Rituxan Side Effects Report #5127601-X
Rituxan side effect was reported by a Physician from JAPAN on Sept 26, 2006. Male patient, 80 years of age, was diagnosed with microscopic polyangiitis and was treated with Rituxan. After drug was administered, patient experienced the following side effects: haematocrit decreased, haemoglobin decreased, laboratory test abnormal, pneumonia , sepsis , white blood cell count decreased. Rituxan dosage: 600 MG, QD, INTRAVENOUS. During the same period patient was treated with STEROID, CYCLOSPORINE. Patient died.

Rituxan Side Effects Report #5140715-3
Rituxan side effect was reported by a Physician from JAPAN on Oct 12, 2006. Male patient, 80 years of age, was diagnosed with microscopic polyangiitis and was treated with Rituxan. After drug was administered, patient experienced the following side effects: aspergillosis, blood beta-d-glucan decreased, c-reactive protein increased, cytomegalovirus chorioretinitis, cytomegalovirus infection , haematocrit decreased, haemoglobin decreased, lung neoplasm, platelet count decreased. Rituxan dosage: 600 MG, QD, INTRAVENOUS. During the same period patient was treated with STEROID, CYCLOSPORINE, VALGANCICLOVIR HYDROCHLORIDE. Patient died.

Rituxan Side Effects Report #4720748-9
Rituxan side effect was reported by a Health Professional from UNITED STATES on July 07, 2005. Male patient, 70 years of age, weighting 144.0 lb, was diagnosed with mantle cell lymphoma and was treated with Rituxan. After drug was administered, patient experienced the following side effects: blood pressure diastolic decreased, febrile neutropenia, haemoglobin decreased, nasal congestion, pharyngolaryngeal pain, productive cough, respiratory rate increased, white blood cell count decreased. Rituxan dosage: 375 MG/M2, Q3W, INTRAVENOUS. During the same period patient was treated with GENASENSE, CYCLOPHOSPHAMIDE, DOXORUBIN, VINCRISTINE, PREDNISONE, FILGRASTIM, PEGFILGRASTIM. Patient was hospitalized. Patient recovered.

Rituxan Side Effects Report #4577783-3
Rituxan side effect was reported by a Physician from on Jan 28, 2005. Male patient, 62 years of age, was diagnosed with mantle cell lymphoma and was treated with Rituxan. After drug was administered, patient experienced the following side effects: back pain , culture urine positive, enterococcal infection, fatigue, febrile neutropenia, haematocrit decreased, haemoglobin decreased, platelet count decreased. Rituxan dosage: 375 MG/M2, Q3W; INTRAVENOUS. During the same period patient was treated with GENASENSE, CYCLOPHOSPHAMIDE, DOXORUBICIN HYDROCHLORIDE, VINCRISTINE, PREDNISONE, ACETAMINOPHEN, ALLOPURINOL, VERAPAMIL. Patient was hospitalized. Patient recovered.

Rituxan Side Effects Report #4678285-6
Rituxan side effect was reported by a Physician from on May 13, 2005. Female patient, 53 years of age, was diagnosed with mantle cell lymphoma and was treated with Rituxan. After drug was administered, patient experienced the following side effects: activated partial thromboplastin time shortened, antithrombin iii decreased, blood glucose increased, deep vein thrombosis , fibrin degradation products increased, haemoglobin decreased, platelet count decreased, subileus. Rituxan dosage: 500 MG, INTRAVENOUS. During the same period patient was treated with CYCLOPHOSPHAMIDE, VINCRISTINE, EPIRUBICIN, PREDNISONE, CILOSTAZOL, BETAMETHASONE PHOSPHATE. Patient recovered.

Rituxan Side Effects Report #4713393-2
Rituxan side effect was reported by a Physician from JAPAN on June 28, 2005. Female patient, 53 years of age, was diagnosed with mantle cell lymphoma and was treated with Rituxan. After drug was administered, patient experienced the following side effects: blood glucose increased, deep vein thrombosis , haemoglobin decreased, platelet count decreased, subileus, white blood cell count decreased. Rituxan dosage: 500 MG, INTRAVENOUS. During the same period patient was treated with CYCLOPHOSPHAMIDE, VINCRISTINE, EPIRUBICIN HYDROCHLORIDE, PREDNISONE, CILOSTAZOL, BETAMETHASONE PHOSPHATE. Patient recovered.

Rituxan Side Effects Report #4713406-8
Rituxan side effect was reported by a Physician from JAPAN on June 28, 2005. Female patient, 53 years of age, was diagnosed with mantle cell lymphoma and was treated with Rituxan. After drug was administered, patient experienced the following side effects: blood glucose increased, deep vein thrombosis , haemoglobin decreased, subileus, white blood cell count increased. Rituxan dosage: 500 MG, INTRAVENOUS. During the same period patient was treated with CYCLOPHOSPHAMIDE, VINCRISTINE, EPIRUBICIN HYDROCHLORIDE, PREDNISONE, CILOSTAZOL, BETAMETHASONE PHOSPHATE. Patient recovered.

Rituxan Side Effects Report #5081336-0
Rituxan side effect was reported by a Physician from UNITED STATES on Aug 02, 2006. Male patient, 64 years of age, was diagnosed with lymphoma  and was treated with Rituxan. After drug was administered, patient experienced the following side effects: bone marrow toxicity, haemoglobin decreased, neutropenia, platelet count decreased. Rituxan dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE, DOXORUBICIN, VINCRISTINE, PREDNISONE. Patient recovered.

Rituxan Side Effects Report #4712565-0
Rituxan side effect was reported by a Physician from UNITED STATES on June 23, 2004. Male patient, 60 years of age, was diagnosed with lung transplant rejection and was treated with Rituxan. After drug was administered, patient experienced the following side effects: blood creatinine increased, blood glucose increased, blood urea increased, bronchitis acute, bronchopulmonary aspergillosis, haematocrit decreased, haemoglobin decreased, lymphocyte percentage decreased, platelet count increased. Rituxan dosage: 705 MG, 1/WEEK, INTRAVENOUS. During the same period patient was treated with PROGRAF, PREDNISONE, CELLCEPT, BACTRIM DS, VORICONAZOLE, AZITHROMYCIN, LANSOPRAZOLE, ATORVASTATIN. Patient recovered.

Rituxan Side Effects Report #4739049-8
Rituxan side effect was reported by a Physician from UNITED STATES on July 07, 2004. Female patient was diagnosed with hairy cell leukaemia and was treated with Rituxan. After drug was administered, patient experienced the following side effects: haemoglobin decreased, neutropenia, thrombocytopenia. Rituxan dosage: 375 MG/M2, INTERAVENOUS. Patient was hospitalized. Patient recovered.


Rituxan Side Effects Report #5090743-1
Rituxan side effect was reported by a Physician from JAPAN on Aug 10, 2006. Female patient, 83 years of age, weighting 99.21 lb, was diagnosed with diffuse large b-cell lymphoma and was treated with Rituxan. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, anorexia, blood immunoglobulin a increased, blood potassium decreased, constipation , feeling abnormal, haemoglobin decreased, headache , interstitial lung disease. Rituxan dosage: 491.2 MG, INTRAVENOUS. During the same period patient was treated with CYCLOPHOSPHAMIDE, DOXORUBICIN, VINCRISTINE, PREDNISONE, IBUPROFEN, POLARAMINE, LOSARTAN POSTASSIUM, AMLODIPINE BESYLATE. Patient was hospitalized. Patient recovered.

Rituxan Side Effects Report #4868767-6
Rituxan side effect was reported by a Physician from JAPAN on Dec 16, 2005. Female patient, 83 years of age, weighting 99.21 lb, was diagnosed with diffuse large b-cell lymphoma and was treated with Rituxan. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, anorexia, blood potassium decreased, constipation , haemoglobin decreased, headache , malaise, nausea , neutrophil count decreased. Rituxan dosage: 491.2 MG, INTRAVENOUS. During the same period patient was treated with CYCLOPHOSPHAMIDE, DOXORUBICIN, VINCRISTINE, PREDNISONE, IBUPROFEN, POLARAMINE, LOSARTAN POTASSIUM, AMLODIPINE BESYLATE. Patient recovered.

Rituxan Side Effects Report #5014379-3
Rituxan side effect was reported by a Physician from JAPAN on May 20, 2006. Female patient, 83 years of age, weighting 99.21 lb, was diagnosed with diffuse large b-cell lymphoma and was treated with Rituxan. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, anorexia, blood immunoglobulin a increased, blood immunoglobulin g increased, blood potassium decreased, constipation , feeling abnormal, haemoglobin decreased, headache . Rituxan dosage: 491.2 MG, INTRAVENOUS. During the same period patient was treated with CYCLOPHOSPHAMIDE, DOXORUBICIN, VINCRISTINE, PREDNISONE, IBUPROFEN, POLARAMINE, ALLOPURINOL, AMLODIPINE BESYLATE. Patient was hospitalized. Patient recovered.

Rituxan Side Effects Report #5227074-2
Rituxan side effect was reported by a Physician from JAPAN on Jan 27, 2007. Female patient, 64 years of age, was diagnosed with diffuse large b-cell lymphoma and was treated with Rituxan. After drug was administered, patient experienced the following side effects: c-reactive protein increased, demyelination, dysstasia, haemoglobin decreased, muscular weakness, nerve conduction studies abnormal, pyrexia, upper respiratory tract inflammation, white blood cell count increased. Rituxan dosage: 515 MG, QD, INTRAVENOUS. During the same period patient was treated with ONCOVIN, DOXORUBICIN, CYCLOPHOSPHAMIDE, PREDNISONE, CALONAL, POLARAMINE, ZANTAC. Patient was hospitalized. Patient recovered.

Rituxan Side Effects Report #5127269-2
Rituxan side effect was reported by a Physician from JAPAN on Sept 26, 2006. Female patient, 64 years of age, was diagnosed with diffuse large b-cell lymphoma and was treated with Rituxan. After drug was administered, patient experienced the following side effects: csf cell count abnormal, csf protein increased, dysstasia, haemoglobin decreased, muscular weakness, neutrophil percentage decreased, pyrexia, upper respiratory tract inflammation, wheelchair user. Rituxan dosage: 515 MG, QD, INTRAVENOUS. During the same period patient was treated with ONCOVIN, DOXORUBICIN, CYCLOPHOSPHAMIDE, PREDNISONE, CALONAL, POLARAMINE, ZANTAC. Patient was hospitalized. Patient recovered.

Rituxan Side Effects Report #5167467-5
Rituxan side effect was reported by a Physician from JAPAN on Nov 16, 2006. Female patient, 64 years of age, was diagnosed with diffuse large b-cell lymphoma and was treated with Rituxan. After drug was administered, patient experienced the following side effects: csf protein increased, demyelination, dysstasia, haemoglobin decreased, muscular weakness, nerve conduction studies abnormal, neutrophil percentage decreased, pyrexia, upper respiratory tract inflammation. Rituxan dosage: 515 MG, QD; INTRAVENOUS. During the same period patient was treated with ONCOVIN, DOXORUBICIN, CYCLOPHOSPHAMIDE, PREDNISONE, CALONAL, POLARAMINE, ZANTAC. Patient was hospitalized. Patient recovered.

Rituxan Side Effects Report #4739050-4
Rituxan side effect was reported by a Pharmacist from UNITED STATES on Sept 16, 2004. Female patient, 75 years of age, weighting 136.0 lb, was diagnosed with chronic lymphocytic leukaemia and was treated with Rituxan. After drug was administered, patient experienced the following side effects: haemoglobin decreased, malaise, platelet count decreased, pyrexia, rash . Rituxan dosage: 610 MG, 1/WEEK, INTRAVENOUS. During the same period patient was treated with DIPHENHYDRAMINE, IBUPROFEN, ACETAMINOPHEN. Patient was hospitalized. Patient recovered.

Rituxan Side Effects Report #4741984-1
Rituxan side effect was reported by a Pharmacist from UNITED STATES on Sept 16, 2004. Female patient, 75 years of age, weighting 136.0 lb, was diagnosed with chronic lymphocytic leukaemia and was treated with Rituxan. After drug was administered, patient experienced the following side effects: haemoglobin decreased, malaise, platelet count decreased, pyrexia, rash . Rituxan dosage: 610 MG, 1/WEEK, INTRAVENOUS. During the same period patient was treated with DIPHENHYDRAMINE, IBUPROFEN, ACETAMINOPHEN. Patient was hospitalized. Patient recovered.

Rituxan Side Effects Report #5209254-5
Rituxan side effect was reported by a Consumer or non-health professional from UNITED STATES on Jan 02, 2007. Male patient, 73 years of age, weighting 176.4 lb, was diagnosed with chronic lymphocytic leukaemia and was treated with Rituxan. After drug was administered, patient experienced the following side effects: bladder stenosis, blood creatinine increased, blood urea increased, cystitis haemorrhagic, haemoglobin decreased, neutropenia, ureteritis. Rituxan dosage: 375 MG/M2, INTRAVENOUS. During the same period patient was treated with FLUDARABINE PHOSPHATE, CAMPATH, ALLOPURINOL, SULFAMETHOXAZOLE, LORTAB, DITROPAN, COLACE, SENNA. Patient was hospitalized. Patient recovered.

Rituxan Side Effects Report #4825224-0
Rituxan side effect was reported by a Health Professional from JAPAN on Oct 27, 2005. Female patient, 43 years of age, weighting 105.8 lb, was diagnosed with b-cell lymphoma and was treated with Rituxan. After drug was administered, patient experienced the following side effects: blood lactate dehydrogenase increased, haemoglobin decreased, neutropenia, peritoneal perforation, peritonitis, platelet count decreased, white blood cell count decreased. Rituxan dosage: 545.62 MG, SINGLE, INTRAVENOUS. During the same period patient was treated with VINCRISTINE, DOXORUBICIN, ETOPOSIDE, CYCLOPHOSPHAMIDE, PREDNISONE, ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE. Patient recovered.


Rituxan Side Effects Report #4979159-3
Rituxan side effect was reported by a Physician from JAPAN on Apr 05, 2006. Female patient was diagnosed with b-cell lymphoma and was treated with Rituxan. After drug was administered, patient experienced the following side effects: condition aggravated, encephalitis , encephalopathy, haemoglobin decreased, large intestinal haemorrhage, nuclear magnetic resonance imaging brain abnormal, pneumonia , viral infection . Rituxan dosage: unknown. During the same period patient was treated with PREDNISOLONE PHOSPHATE, MAXIPIME, POLARAMINE, SAXIZON. Patient died on 11/03/2005.

Rituxan Side Effects Report #5007051-7
Rituxan side effect was reported by a Physician from JAPAN on May 08, 2006. Female patient was diagnosed with b-cell lymphoma and was treated with Rituxan. After drug was administered, patient experienced the following side effects: brain oedema, encephalitis , encephalitis viral, encephalopathy, haemoglobin decreased, large intestinal haemorrhage, lymphocyte percentage decreased, neutrophil percentage increased, platelet count decreased. Rituxan dosage: 470 MG, INTRAVENOUS; SEE IMAGE. During the same period patient was treated with PREDNISOLONE PHOSPHATE, MAXIPIME, POLARAMINE, SAXIZON. Patient died on 11/03/2005.

Rituxan Side Effects Report #4614094-1
Rituxan side effect was reported by a Consumer or non-health professional from on Mar 02, 2005. Female patient, 74 years of age, was treated with Rituxan. After drug was administered, patient experienced the following side effects: blood immunoglobulin m increased, haemoglobin decreased, heart rate increased. Rituxan dosage: unknown. During the same period patient was treated with PEPCID, VITAMINS, LEVAQUIN, SYNTHROID. Patient recovered.

Rituxan Side Effects Report #4775474-7
Rituxan side effect was reported by a Physician from UNITED STATES on Sept 21, 2005. Female patient, 70 years of age, was treated with Rituxan. After drug was administered, patient experienced the following side effects: abdominal distension, abdominal pain , haemoglobin decreased, platelet count decreased, pyrexia, white blood cell count decreased. Rituxan dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE, DOXORUBICIN, VINCRISTINE, PREDNISONE, DOXIL. Patient recovered.

Rituxan Side Effects Report #5072728-4
Rituxan side effect was reported by a Physician from UNITED STATES on July 21, 2006. Male patient, 64 years of age, was treated with Rituxan. After drug was administered, patient experienced the following side effects: bone marrow toxicity, haemoglobin decreased, neutropenia, platelet count decreased. Rituxan dosage: unknown. Patient recovered.